Source link : https://newshealth.biz/health-news/mezigdomide-triplet-improves-pfs-in-r-r-multiple-myeloma/
A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma. Medscape Medical News Source link : https://www.medscape.com/viewarticle/mezigdomide-triplet-improves-pfs-r-r-multiple-myeloma-2026a1000lzr?src=rss Author : Publish date : 2026-06-29 12:02:00 Copyright for syndicated content belongs to the linked Source.
The post Mezigdomide Triplet Improves PFS in R/R Multiple Myeloma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-29 12:02:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8